Shipping ADCs with Confidence: Eliminating the Risks That Keep Program Leaders Up at Night
Antibody-drug conjugates (ADCs) represent some of the most promising, and most complex, therapies in...
read Details
C> is vulnerable to violent shock during transportation.
C> is vulnerable to violent shock during transportation.
Modality Solutions is paving the way for the future of pharmaceutical transportation testing.
The global cold chain requires non-standard modes of transportation like speedboats, helicopters, drones, and more. Lack of infrastructure shouldn’t stop therapies from getting where they need to go. Real-world shipping tests aren’t effective for measuring viability, which is why Modality Solutions’ Advantage Transport Simulation Laboratory™ conducts worst-case scenarios.
Stay on top of the industry trends
You may also like
Misalignment Is a Silent Killer—And the FDA Is Looking for Cracks
FDA Uncertainty: Why First-Cycle Approval Is Now a Matter of Survival Leadership shake-ups, budget...
read Details
In This New Regulatory Landscape, You’re Either Ready—or at Risk
FDA Uncertainty: Why First-Cycle Approval Is Now a Matter of Survival Leadership shake-ups, budget...
read Details